OI Olopade

462 total citations
10 papers, 305 citations indexed

About

OI Olopade is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, OI Olopade has authored 10 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in OI Olopade's work include Cancer-related Molecular Pathways (2 papers), Asthma and respiratory diseases (2 papers) and Advanced Breast Cancer Therapies (1 paper). OI Olopade is often cited by papers focused on Cancer-related Molecular Pathways (2 papers), Asthma and respiratory diseases (2 papers) and Advanced Breast Cancer Therapies (1 paper). OI Olopade collaborates with scholars based in United States and Nigeria. OI Olopade's co-authors include Rosemarie Mick, Fitsum Hagos, Wendy Recant, Moses Adeyanju, Ahmad R. Safa, Curtis B. Thompson, Maya Thangavelu, Richard A. Larson, JD Rowley and H. Ralph Schumacher and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

OI Olopade

9 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
OI Olopade United States	4	207	70	68	42	36	10	305
Stephen M. Hart United Kingdom	9	243 1.2×	121 1.7×	57 0.8×	46 1.1×	27 0.8×	10	367
M. Georget France	5	78 0.4×	78 1.1×	74 1.1×	42 1.0×	22 0.6×	6	287
Leandro F. Dalmazzo Brazil	7	206 1.0×	52 0.7×	80 1.2×	31 0.7×	78 2.2×	13	330
Irina Mantovani Italy	8	291 1.4×	98 1.4×	74 1.1×	39 0.9×	38 1.1×	10	381
Elena G. Bamberger United States	6	195 0.9×	53 0.8×	85 1.3×	33 0.8×	26 0.7×	17	354
Marlena Walls United States	8	202 1.0×	84 1.2×	26 0.4×	16 0.4×	33 0.9×	11	312
Marcos J. Ruiz United States	3	135 0.7×	124 1.8×	87 1.3×	45 1.1×	23 0.6×	5	269
Alessandra Pirola Italy	12	202 1.0×	84 1.2×	79 1.2×	50 1.2×	73 2.0×	24	344
Line Wergeland Norway	10	212 1.0×	92 1.3×	225 3.3×	42 1.0×	51 1.4×	13	386
Nandini Ramachandra United States	8	241 1.2×	112 1.6×	123 1.8×	38 0.9×	68 1.9×	15	450

Countries citing papers authored by OI Olopade

Since Specialization

Citations

This map shows the geographic impact of OI Olopade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by OI Olopade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites OI Olopade more than expected).

Fields of papers citing papers by OI Olopade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by OI Olopade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by OI Olopade. The network helps show where OI Olopade may publish in the future.

Co-authorship network of co-authors of OI Olopade

This figure shows the co-authorship network connecting the top 25 collaborators of OI Olopade. A scholar is included among the top collaborators of OI Olopade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with OI Olopade. OI Olopade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Rahman, Ganiyu A., et al.. (2016). Survivorship patterns of histopathological variants and molecular subtypes of breast cancer in a teaching hospital in Nigeria. East African Medical Journal. 93(9). 459–465. 1 indexed citations

Yau, Christopher, Jiapeng Deng, Lamorna Brown Swigart, et al.. (2016). Abstract P3-07-48: Prediction of complete pathologic response to veliparib/carboplatin plus standard neoadjuvant therapy in HER2 negative breast cancer: Exploratory protein pathway marker results from the I-SPY 2 trial. Cancer Research. 76(4_Supplement). P3–7. 2 indexed citations

Ige, O., O.G. Arinola, Oluwafemi Oluwole, et al.. (2011). Atopy Is Associated with Asthma in Adults Living in Rural and Urban Southwestern Nigeria. Journal of Asthma. 48(9). 894–900. 7 indexed citations

Melhem‐Bertrandt, Amal, et al.. (2010). Abstract P3-12-01: Increased Rate of HER2-Positive Breast Cancers among Women with Germline TP53 Mutations. Cancer Research. 70(24_Supplement). P3–12. 1 indexed citations

Arinola, OG, et al.. (2009). Atopy, Helminthic Infection and Serum Immunoglobulins in Adult Asthma in SW Nigeria.. A1293–A1293. 1 indexed citations

Olopade, OI, et al.. (2009). Fluvastatin has biologic effects on stage 0 and 1 breast cancer.. Cancer Research. 69(2_Supplement). 4122–4122. 1 indexed citations

Ikpatt, Francis, James J. Dignam, Andrey Khramtsov, et al.. (2004). Breast tumor morphometry in relation to race reveals significant differences among Nigerians, African-Americans and Caucasian Americans. Journal of Clinical Oncology. 22(14_suppl). 9567–9567. 1 indexed citations

Olopade, OI, Moses Adeyanju, Ahmad R. Safa, et al.. (1997). Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.. PubMed. 3(4). 230–7. 172 indexed citations

Nobori, Tsutomu, Diane Amox, Bruce L. Parker, et al.. (1993). Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers.. PubMed. 53(5). 1098–101. 46 indexed citations

10.

Olopade, OI, Maya Thangavelu, Richard A. Larson, et al.. (1992). Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood. 80(11). 2873–2882. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact